The efficacy and safety of besifloxacin for acute bacterial conjunctivitis: a Meta-analysis.
Int J Ophthalmol, 2019 Wang JJ, Gao XY, Li HZ, Du SS.
europepmc +1 more source
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates. [PDF]
Drugs R D, 2017 Sanfilippo CM, Allaire CM, DeCory HH.
europepmc +1 more source
In Vitro Bactericidal Activity of Propamidine 0.1% and Other Ophthalmic Antiseptics on Conjunctivitis and Blepharitis Strains. [PDF]
Ophthalmol TherPaschier A +4 more
europepmc +1 more source
An unusual presentation of meningococcal meningitis. [PDF]
Am J Ophthalmol Case RepKhan AZ, Fineide F, Utheim TP.
europepmc +1 more source
Neonatal conjunctivitis due to uncommon pathogen Streptococcus mitis/oralis: a case report. [PDF]
BMC OphthalmolKılınç AK +3 more
europepmc +1 more source
Recurrent Red Eye Misdiagnosed as Conjunctivitis: Ocular Rosacea With Corneal Neovascularization in a Young Patient. [PDF]
CureusFerreira J +4 more
europepmc +1 more source
Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. [PDF]
Dermatol Ther (Heidelb)Yosipovitch G +8 more
europepmc +1 more source
Adult bacterial conjunctivitis: resistance patterns over 12 years in patients attending a large primary eye care centre in the UK. [PDF]
BMJ Open Ophthalmol, 2017 Silvester A +5 more
europepmc +1 more source
Evaluation and modulation of bactericidal potential of different antibacterial agents against bacterial pathogens from conjunctivitis infections. [PDF]
J Ophthalmic Inflamm InfectArshad S +6 more
europepmc +1 more source